TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 EUR)
Closing information | 2021/12 (consolidated) | 2020/12 (consolidated) | 2019/12 (consolidated) |
Turnover |
2,515,734
|
2,392,534
|
2,216,891 |
Financial expenses |
21,263
|
1,010
|
1,021 |
Earnings before taxes |
473,177
|
393,300
|
435,314 |
EBITDA |
635,335
|
520,167 | |
Total assets |
3,882,799
|
3,412,186
|
3,195,762 |
Current assets |
2,720,983
|
2,404,640
|
2,284,881 |
Current liabilities |
391,765
|
309,344
|
347,209 |
Equity capital |
3,299,092
|
2,910,781
|
2,667,635 |
- share capital |
120
|
100
![]() |
100 |
Employees (average) |
8,336
|
8,141
|
7,908 |
Financial ratios
Fiscal year | 2021/12 (consolidated) | 2020/12 (consolidated) | 2019/12 (consolidated) |
Solvency |
85.0%
|
85.3%
|
83.5% |
Turnover per employee |
302
|
294
|
280 |
Profit as a percentage of turnover |
18.8%
|
16.4%
|
19.6% |
Return on assets (ROA) |
12.7%
|
11.6%
|
13.7% |
Current ratio |
694.5%
|
777.3%
|
658.1% |
Return on equity (ROE) |
14.3%
|
13.5%
|
16.3% |
Change turnover |
167,509
|
88,160
|
450,562 |
Change turnover % |
7%
|
4%
|
26% |
Chg. No. of employees |
195
|
233
|
352 |
Chg. No. of employees % |
2%
|
3%
|
5% |
Total value of public sale
Fiscal year | 2021/12 (consolidated) | 2020/12 (consolidated) | 2019/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.